<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01818531</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00023002</org_study_id>
    <nct_id>NCT01818531</nct_id>
  </id_info>
  <brief_title>Adductor Canal Block for Medial Compartment Knee Arthroplasty</brief_title>
  <official_title>Evaluation of Ultrasound-Guided Adductor Canal Blockade for Postoperative Analgesia Following Robotic Medial Unicompartmental Knee Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the affects of a single injection ultrasound-guided adductor canal
      block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee
      arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia
      provided by the adductor canal block with that provided by single injection lumbar plexus
      blockade. The working hypothesis is that the analgesia provided by the adductor canal block
      will be equivalent to the analgesia provided by the lumbar plexus block. The primary outcome
      will be a comparison of verbal numerical pain scores at rest and with movement over the first
      24 hours following nerve blockade.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Verbal pain scores at 6 hours post nerve blockade.</measure>
    <time_frame>6 hours post block.</time_frame>
    <description>Comparison of verbal numerical pain scores at rest and with movement over the first 24 hours following nerve blockade.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Comparison of opioid consumption over 24 hour period between adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic</measure>
    <time_frame>24 hours</time_frame>
    <description>Time to first analgesic between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid related side effects</measure>
    <time_frame>24 hours</time_frame>
    <description>Occurrence of opioid related side effects (nausea, vomiting and itching) between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quadriceps motor strength</measure>
    <time_frame>6 hours</time_frame>
    <description>Comparison of quadriceps motor strength at 6 hour post nerve block between two groups: adductor canal block and lumbar plexus block.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Postoperative Analgesia</condition>
  <condition>Medial Unicompartmental Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Adductor canal block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will receive an adductor canal block prior to undergoing a medial compartment knee arthroplasty.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lumbar plexus block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm will receive a lumbar plexus block prior to undergoing a medial compartment knee arthroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adductor canal block</intervention_name>
    <arm_group_label>Adductor canal block</arm_group_label>
    <other_name>Saphenous nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lumbar plexus block</intervention_name>
    <arm_group_label>Lumbar plexus block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-85

          -  Undergoing unilateral robotic-assisted (MAKOplasty) medial compartment knee
             arthroplasty at Wake Forest University Baptist Medical Center.

          -  Must give written informed consent for anesthesia including subarachnoid blockade and
             peripheral nerve blockade of both the lumbar plexus and adductor canal.

          -  Must consent to the performance of a sham block at the site to which they are not
             randomized.

          -  Must also be reliable to give accurate verbal pain scores postoperatively.

        Exclusion Criteria:

          -  Contraindication to adductor canal blockade or lumbar plexus blockade (including
             significant coagulation abnormalities)

          -  History of opioid addiction or current chronic pain therapy for pain other than at the
             surgical site that is being treated with high-dose opioids (extended release opioids
             or &gt; 40mg oxycodone equivalents per day)

          -  Allergy to study medications

          -  Failure to adequately place either the adductor canal or lumbar plexus blocks.

          -  Patients who decline or have a contraindication to subarachnoid blockade will also be
             excluded from the study.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daryl S Henshaw, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Meek RM, Masri BA, Duncan CP. Minimally invasive unicompartmental knee replacement: rationale and correct indications. Orthop Clin North Am. 2004 Apr;35(2):191-200. Review.</citation>
    <PMID>15062705</PMID>
  </reference>
  <reference>
    <citation>Riddle DL, Jiranek WA, McGlynn FJ. Yearly incidence of unicompartmental knee arthroplasty in the United States. J Arthroplasty. 2008 Apr;23(3):408-12. doi: 10.1016/j.arth.2007.04.012. Epub 2007 Nov 26.</citation>
    <PMID>18358380</PMID>
  </reference>
  <reference>
    <citation>Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.</citation>
    <PMID>17403800</PMID>
  </reference>
  <reference>
    <citation>GARDNER E. The innervation of the knee joint. Anat Rec. 1948 May;101(1):109-30.</citation>
    <PMID>18915634</PMID>
  </reference>
  <reference>
    <citation>Davis JJ, Bond TS, Swenson JD. Adductor canal block: more than just the saphenous nerve? Reg Anesth Pain Med. 2009 Nov-Dec;34(6):618-9. doi: 10.1097/AAP.0b013e3181bfbf00.</citation>
    <PMID>19901788</PMID>
  </reference>
  <reference>
    <citation>Horner G, Dellon AL. Innervation of the human knee joint and implications for surgery. Clin Orthop Relat Res. 1994 Apr;(301):221-6.</citation>
    <PMID>8156678</PMID>
  </reference>
  <reference>
    <citation>Jenstrup MT, Jæger P, Lund J, Fomsgaard JS, Bache S, Mathiesen O, Larsen TK, Dahl JB. Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand. 2012 Mar;56(3):357-64. doi: 10.1111/j.1399-6576.2011.02621.x. Epub 2012 Jan 4.</citation>
    <PMID>22221014</PMID>
  </reference>
  <reference>
    <citation>Lund J, Jenstrup MT, Jaeger P, Sørensen AM, Dahl JB. Continuous adductor-canal-blockade for adjuvant post-operative analgesia after major knee surgery: preliminary results. Acta Anaesthesiol Scand. 2011 Jan;55(1):14-9. doi: 10.1111/j.1399-6576.2010.02333.x. Epub 2010 Oct 29.</citation>
    <PMID>21039357</PMID>
  </reference>
  <reference>
    <citation>Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003 May;25(5):406-11.</citation>
    <PMID>12727037</PMID>
  </reference>
  <reference>
    <citation>Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm. 1987 Dec;15(6):657-80.</citation>
    <PMID>3450848</PMID>
  </reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2013</study_first_submitted>
  <study_first_submitted_qc>March 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2013</study_first_posted>
  <last_update_submitted>November 6, 2017</last_update_submitted>
  <last_update_submitted_qc>November 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Partial knee replacement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

